Pascale Olivier

Summary

Country: France

Publications

  1. ncbi request reprint [Adverse cardiovascular and central neurologic reactions to sympathomimetics used as nasal decongestants: results of the French National Pharmacovigilance Survey]
    Pascale Olivier
    Service de Pharmacologie Clinique, centre Midi Pyrénées de pharmacovigilance, de Pharmacoepidemiologie et d Informations sur le Medicament, Centre Hospitalier Universitaire de Toulouse, Faculté de Médecine de Toulouse, Toulouse, France
    Therapie 58:361-6. 2003
  2. ncbi request reprint [Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale]
    Pascale Olivier
    Service de Pharmacologie Clinique, centre Midi Pyrénées de pharmacovigilance, de Pharmacoépidémiologie et d Informations sur le Medicament Inserm U657, Faculte de Medecine, Toulouse, France
    Therapie 60:39-45. 2005
  3. ncbi request reprint The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France
    Pascale Olivier
    Service de Pharmacologie Clinique, centre Midi Pyrénées de pharmacovigilance, de Pharmacoepidemiologie et d Informations sur le Medicament, Faculte de Medecine, Toulouse, France
    Pharmacoepidemiol Drug Saf 15:808-12. 2006
  4. doi request reprint [Post-marketing safety profile of avocado-soybean unsaponifiables]
    Pascale Olivier
    Centre Hospitalier Universitaire de Toulouse, centre Midi Pyrénées de pharmacovigilance, de Pharmacoepidemiologie et d Informations sur le Medicament, Service de Pharmacologie Clinique, 31000 Toulouse, France
    Presse Med 39:e211-6. 2010
  5. ncbi request reprint Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods
    Jean Louis Montastruc
    Medical and Clinical Pharmacology Laboratory, Pharmacoepidemiology Unit, EA 3696, IFR INSERM 126, Paul Sabatier University, School of Medicine, Toulouse, France
    Joint Bone Spine 73:629-32. 2006
  6. doi request reprint Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey
    Pascale Olivier
    Unit of Pharmacoepidemiology, University of Toulouse, Toulouse, France
    Drugs Aging 26:475-82. 2009
  7. doi request reprint [Drug-related neuropathies: analysis of the French Adverse Drug Reaction Database 1995-2005]
    Genevieve Durrieu
    Laboratoire de Pharmacologie Medicale et Clinique, Unité de Pharmacoépidémiologie, EA 3696, Universite Paul Sabatier, Faculte de Medecine, F 31000 Toulouse, France
    Presse Med 37:935-42. 2008
  8. ncbi request reprint [New methods for studying drug associated risk: experience of the Toulouse Regional Pharmacovigilance Center]
    Jean Louis Montastruc
    Laboratoire de Pharmacologie Medicale et Clinique, Unité de Pharmacoépidémiologie, EA 3696, IFR INSERM 126, Faculte de Medecine, 37 Allees Jules Guesde, BP 7202, 31073 Toulouse 7, France
    Bull Acad Natl Med 189:493-502; discussion 502-5. 2005
  9. ncbi request reprint Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department
    Pascale Olivier
    Department of Clinical Pharmacology, centre Midi Pyrénées de pharmacovigilance, Faculty of Medicine, Toulouse University Hospital, Toulouse, France
    Drug Saf 25:1035-44. 2002
  10. ncbi request reprint [Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance]
    Jean Louis Montastruc
    Laboratoire de Pharmacologie Medicale et Clinique, Unité de Pharmacoépidémiologie, UA 3696, IFR 126, Universite Paul Sabatier, Faculte de Medecine, Toulouse, France
    Therapie 61:29-38. 2006

Detail Information

Publications12

  1. ncbi request reprint [Adverse cardiovascular and central neurologic reactions to sympathomimetics used as nasal decongestants: results of the French National Pharmacovigilance Survey]
    Pascale Olivier
    Service de Pharmacologie Clinique, centre Midi Pyrénées de pharmacovigilance, de Pharmacoepidemiologie et d Informations sur le Medicament, Centre Hospitalier Universitaire de Toulouse, Faculté de Médecine de Toulouse, Toulouse, France
    Therapie 58:361-6. 2003
    ..Since most of the nasal decongestants are freely available without prescription, drug information is needed to advise prescribers and also patients about risk of 'serious' ADRs with these drugs...
  2. ncbi request reprint [Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale]
    Pascale Olivier
    Service de Pharmacologie Clinique, centre Midi Pyrénées de pharmacovigilance, de Pharmacoépidémiologie et d Informations sur le Medicament Inserm U657, Faculte de Medecine, Toulouse, France
    Therapie 60:39-45. 2005
    ..This experience suggests the need for further studies to improve this French ADR preventability scale and validate it in differing circumstances, in order to provide a useful tool to enhance the rational use of drugs...
  3. ncbi request reprint The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France
    Pascale Olivier
    Service de Pharmacologie Clinique, centre Midi Pyrénées de pharmacovigilance, de Pharmacoepidemiologie et d Informations sur le Medicament, Faculte de Medecine, Toulouse, France
    Pharmacoepidemiol Drug Saf 15:808-12. 2006
    ..The objective of our study was to determine the scientific evidences leading to drug withdrawal for pharmacovigilance reasons in France...
  4. doi request reprint [Post-marketing safety profile of avocado-soybean unsaponifiables]
    Pascale Olivier
    Centre Hospitalier Universitaire de Toulouse, centre Midi Pyrénées de pharmacovigilance, de Pharmacoepidemiologie et d Informations sur le Medicament, Service de Pharmacologie Clinique, 31000 Toulouse, France
    Presse Med 39:e211-6. 2010
    ..To determine the post-marketing safety profile of avocado-soybean unsaponifiables since their commercialization in France until 2008...
  5. ncbi request reprint Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods
    Jean Louis Montastruc
    Medical and Clinical Pharmacology Laboratory, Pharmacoepidemiology Unit, EA 3696, IFR INSERM 126, Paul Sabatier University, School of Medicine, Toulouse, France
    Joint Bone Spine 73:629-32. 2006
  6. doi request reprint Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey
    Pascale Olivier
    Unit of Pharmacoepidemiology, University of Toulouse, Toulouse, France
    Drugs Aging 26:475-82. 2009
    ..Thus, the aim of this prospective study was to assess the incidence of ADRs and associated factors leading to hospital admissions in the elderly population...
  7. doi request reprint [Drug-related neuropathies: analysis of the French Adverse Drug Reaction Database 1995-2005]
    Genevieve Durrieu
    Laboratoire de Pharmacologie Medicale et Clinique, Unité de Pharmacoépidémiologie, EA 3696, Universite Paul Sabatier, Faculte de Medecine, F 31000 Toulouse, France
    Presse Med 37:935-42. 2008
    ..Drug-induced neuropathies are mainly sensory and subacute. The pathophysiological mechanisms associated with them are not clearly established and few pharmacoepidemiologic studies are available...
  8. ncbi request reprint [New methods for studying drug associated risk: experience of the Toulouse Regional Pharmacovigilance Center]
    Jean Louis Montastruc
    Laboratoire de Pharmacologie Medicale et Clinique, Unité de Pharmacoépidémiologie, EA 3696, IFR INSERM 126, Faculte de Medecine, 37 Allees Jules Guesde, BP 7202, 31073 Toulouse 7, France
    Bull Acad Natl Med 189:493-502; discussion 502-5. 2005
    ..Finally, ADR perception analysis is a useful method to evaluate the perceived social and medical importance of drug risks in different populations (public, pharmacists, general practitioners, medical specialists)...
  9. ncbi request reprint Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department
    Pascale Olivier
    Department of Clinical Pharmacology, centre Midi Pyrénées de pharmacovigilance, Faculty of Medicine, Toulouse University Hospital, Toulouse, France
    Drug Saf 25:1035-44. 2002
    ..To assess the preventability of adverse drug reactions (ADRs) leading to hospital admissions and to investigate the feasibility of the use of a standardised preventability scale in clinical practice...
  10. ncbi request reprint [Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance]
    Jean Louis Montastruc
    Laboratoire de Pharmacologie Medicale et Clinique, Unité de Pharmacoépidémiologie, UA 3696, IFR 126, Universite Paul Sabatier, Faculte de Medecine, Toulouse, France
    Therapie 61:29-38. 2006
    ..It is also an important mediator for pleasure, hedonic regulations and sexual behaviour. This review also underlines the major role of spontaneous reports to the pharmacovigilance systems to identify new adverse drug reactions...
  11. pmc Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
    Stéphanie Berthet
    Unité INSERM 1027, Equipe de Pharmacoépidémiologie, Universite de Toulouse, Toulouse, France
    BMC Clin Pharmacol 11:5. 2011
    ..The aim of our study was to investigate the profile of adverse drug reactions (ADRs) related to TZDs and to investigate potential risk factors of these ADRs...
  12. ncbi request reprint Gynecomastia associated with fenofibrate
    Virginie Gardette
    Service de Pharmacologie Clinique, centre Midi Pyrénées de pharmacovigilance, de Pharmacoepidemiologie et d Informations sur le Medicament, Faculte de Medecine, Universite Toulouse III Paul Sabatier, Toulouse, France
    Ann Pharmacother 41:508-10. 2007
    ..To report a case of probable fenofibrate-induced gynecomastia...